Fabrazyme 35 mg, powder for concentrate for solution for infusion

Company:
Sanofi Genzyme
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Agalsidase Beta
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/01/188/001-002

35 milligram(s)

A16AB,A16AB04

Pdr/Conc/Soln for Infusion

EU/1/01/188/003

35 milligram(s)

A16AB,A16AB04

Pdr/Conc/Soln for Infusion